Early Treatment May Delay Alzheimer’s Symptoms in Asymptomatic Patients
Researchers have found that long-term removal of amyloid beta in people genetically destined to develop Alzheimer’s disease may delay symptoms and disease progression. A study published in Lancet Neurology suggests that treating asymptomatic Alzheimer’s disease might reduce progression. A total of 53 asymptomatic individuals with dominantly inherited Alzheimer’s disease were treated with investigational gantenerumab in … Read more